These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 1299941
1. [Management of the treatment with converting enzyme inhibitors in chronic heart failure]. Zannad F. Rev Prat; 1992 Dec 15; 42(20):2563-7. PubMed ID: 1299941 [Abstract] [Full Text] [Related]
3. Role and optimal dosing of angiotensin-converting enzyme inhibitors in heart failure. Kazi D, Deswal A. Cardiol Clin; 2008 Feb 15; 26(1):1-14, v. PubMed ID: 18312901 [Abstract] [Full Text] [Related]
4. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure. Bauersachs J, Fraccarollo D. Minerva Cardioangiol; 2003 Apr 15; 51(2):155-64. PubMed ID: 12783071 [Abstract] [Full Text] [Related]
5. Angiotensin-converting enzyme inhibitors in hypertension: a review. Salvetti A, Pedrinelli R, Arzilli F, Abdel-Haq B, Magagna A, Lucarini A, Graziadei L, Nuccorini A, Taddei S. Int J Clin Pharmacol Res; 1985 Apr 15; 5(6):429-38. PubMed ID: 3005182 [Abstract] [Full Text] [Related]
6. Suppression of the renin-angiotensin-aldosterone system in chronic heart failure: choice of agents and clinical impact. Jorde UP. Cardiol Rev; 2006 Apr 15; 14(2):81-7. PubMed ID: 16493245 [Abstract] [Full Text] [Related]
7. Evolving rationale for angiotensin-converting enzyme inhibition in chronic heart failure. Banerjee A, Talreja A, Sonnenblick EH, LeJemtel TH. Mt Sinai J Med; 2003 Sep 15; 70(4):225-31. PubMed ID: 12968195 [Abstract] [Full Text] [Related]
8. [Cardiac insufficiency: what treatment? what dose? For which patients? Converting enzyme inhibitors and diuretics]. Komajda M. Arch Mal Coeur Vaiss; 2000 Feb 15; 93 Spec No 2():13-6. PubMed ID: 10830083 [Abstract] [Full Text] [Related]
9. The current status of angiotensin converting enzyme inhibitors in the management of patients with chronic heart failure. Packer M, Kukin ML, Neuberg GW, Pinsky DJ, Penn J, Abittan MH. J Hypertens Suppl; 1989 Sep 15; 7(5):S33-6. PubMed ID: 2681605 [Abstract] [Full Text] [Related]
10. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition. van de Wal RM, Plokker HW, Lok DJ, Boomsma F, van der Horst FA, van Veldhuisen DJ, van Gilst WH, Voors AA. Int J Cardiol; 2006 Jan 26; 106(3):367-72. PubMed ID: 16337046 [Abstract] [Full Text] [Related]
18. [Treatment by angiotensin converting enzyme inhibitors after myocardial infarction. What did the clinical trials teach us?]. Guéret P, Garot J, Barnier P. Arch Mal Coeur Vaiss; 1996 Aug 26; 89 Spec No 3():33-8. PubMed ID: 8949316 [Abstract] [Full Text] [Related]
19. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success]. Borghi C, Cosentino E, De Sanctis D. Ital Heart J Suppl; 2005 Dec 26; 6(12):769-79. PubMed ID: 16444921 [Abstract] [Full Text] [Related]
20. High-versus low-dose ACE inhibitor therapy in chronic heart failure. Roffman DS. Ann Pharmacother; 2004 May 26; 38(5):831-8. PubMed ID: 15026561 [Abstract] [Full Text] [Related] Page: [Next] [New Search]